SCHEMBL5326748

SCHEMBL5326748

CC(=O)NCCNC1=C(C)C(=O)C(NC(C)=O)=CC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
S100A4 P26447 1/20 0.38
PIK3CG P48736 1/20 0.35
CA12 O43570 1/20 0.35
CA4 P22748 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
MALT1 Q9UDY8 1/20 0.34
MTNR1A P48039 2/20 0.33
MTNR1B P49286 2/20 0.33
CNR1 P21554 1/20 0.33
IDO1 P14902 1/20 0.33
CYP1A2 P05177 6/20 0.33
CYP3A4 P08684 5/20 0.33
HSD17B10 Q99714 5/20 0.33
ALOX15 P16050 4/20 0.33
ALDH1A1 P00352 4/20 0.33
LMNA P02545 2/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5328420 0.86 TDP1 (0.41) TDP1S100A4IDO1ALDH1A1RAB9A
SCHEMBL5328866 0.81 TDP1 (0.42) TDP1S100A4MALT1IDO1HSD17B10
SCHEMBL5329038 0.79 TDP1 (0.40) TDP1S100A4PIK3CGIDO1HSD17B10
SCHEMBL14386783 0.70 TDP1 (0.49) TDP1S100A4CA12CA9IDO1
SCHEMBL5330070 0.69 TDP1 (0.47) TDP1S100A4IDO1CYP1A2ALDH1A1
SCHEMBL7898077 0.66 NSD2 (0.40) TDP1S100A4IDO1CYP1A2CYP3A4
SCHEMBL11241564 0.65 TDP1 (0.42) TDP1S100A4CA9IDO1HSD17B10
SCHEMBL28654605 0.62 TDP1 (0.46) TDP1S100A4CA12CA4CA7
SCHEMBL8107 0.61 KDM4E (0.71) CA12CA4CA7CA9CA14
SCHEMBL8653625 0.61 RAB9A (0.72) TDP1S100A4IDO1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO claimed
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO disclosed
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO disclosed